Stock FATE FATE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Fate Therapeutics, Inc.

Equities

FATE

US31189P1021

Market Closed - Nasdaq
Other stock markets
 04:00:02 2024-05-16 pm EDT 		5-day change 1st Jan Change
4.15 USD -2.12% Intraday chart for Fate Therapeutics, Inc. +6.41% +10.96%
May. 10 Piper Sandler Adjusts Fate Therapeutics' Price Target to $4 From $7, Keeps Neutral Rating MT
May. 10 Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
FATE THERAPEUTICS, INC. Stock Fate Therapeutics, Inc.
 471M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 104B
ARGENX SE Stock argenx SE
 22.28B -
BIONTECH SE Stock BioNTech SE
 22.41B -
GENMAB A/S Stock Genmab A/S
 19.07B
  1. Stock Market
  2. Equities
  3. FATE Stock
  4. Charts Fate Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW